Dormant liver metastases: an experimental study.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 1555087)

Published in Br J Surg on March 01, 1992

Authors

Y Panis1, J Ribeiro, Y Chrétien, B Nordlinger

Author Affiliations

1: Laboratoire de Chirurgie, Hépatique Expérimentale, (INSERM U181), Hôpital Saint-Antoine, Paris, France.

Articles citing this

Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33

Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) Ann Surg (1998) 2.20

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A (1993) 1.63

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer (2008) 1.26

Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas. Surgery (2007) 1.06

Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. Ann Surg (2000) 1.02

Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol (2015) 0.96

Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer. Ann Surg (2002) 0.90

Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer. Am J Cancer Res (2012) 0.89

A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment. BMC Cancer (2010) 0.87

Impact of Preoperative Neutrophil to Lymphocyte Ratio and Postoperative Infectious Complications on Survival After Curative Gastrectomy for Gastric Cancer: A Single Institutional Cohort Study. Medicine (Baltimore) (2016) 0.86

Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells. Clin Exp Metastasis (2007) 0.85

B16F10 melanoma cell colonization of mouse lung is enhanced by partial pneumonectomy. Clin Exp Metastasis (2002) 0.84

Tumour progression and liver regeneration--insights from animal models. Nat Rev Gastroenterol Hepatol (2013) 0.84

Macrophage inflammatory protein-2 contributes to liver resection-induced acceleration of hepatic metastatic tumor growth. World J Gastroenterol (2006) 0.81

The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation. Cancer Microenviron (2011) 0.81

Increased growth of colorectal liver metastasis following partial hepatectomy. Clin Exp Metastasis (2013) 0.79

Comparison between interstitial laser thermotherapy and excision of an adenocarcinoma transplanted into rat liver. Br J Cancer (1998) 0.79

Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol (2006) 0.77

Effect of gene therapy with the herpes simplex virus-thymidine kinase gene on hepatic metastasis in murine colon cancer. Surg Today (1997) 0.77

Bilobar colorectal liver metastases: a new model for preclinical studies. Int J Exp Pathol (2012) 0.76

Strategies for resection using portal vein embolization: metastatic liver cancer. Semin Intervent Radiol (2008) 0.75

Assessment of Tumor Response and Resection Rates in Unresectable Colorectal Liver Metastases Following Neoadjuvant Chemotherapy with Cetuximab. Indian J Surg Oncol (2015) 0.75

Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastases. Ann Oncol (2015) 0.75

Articles by these authors

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol (2000) 4.25

Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med (1998) 3.68

Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res (1995) 2.84

Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg (1987) 2.58

Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol (2010) 2.54

Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg (1989) 2.40

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. J Clin Oncol (2005) 2.19

Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie. Br J Surg (1997) 2.18

Unusual fat-containing tumors of the kidney: a diagnostic dilemma. Radiographics (1997) 2.14

Normothermic hepatic vascular exclusion for extensive hepatectomy. Surg Gynecol Obstet (1978) 2.13

Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med (1979) 2.11

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology (1999) 2.05

Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg (1988) 1.87

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol (2012) 1.84

Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery (1984) 1.76

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.73

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol (2010) 1.69

Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer (2002) 1.66

Risk stratification systems for diabetic foot ulcers: a systematic review. Diabetologia (2011) 1.64

Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats. Hepatology (1992) 1.60

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. Eur J Cancer (2005) 1.58

Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy. Arch Surg (1978) 1.55

Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. Tumori (1998) 1.54

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet (1987) 1.52

Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg (2005) 1.46

Compartment syndromes associated with postoperative epidural analgesia. A case report. J Bone Joint Surg Am (1996) 1.44

The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol (2007) 1.44

Cholestasis induces major histocompatibility complex class I expression in hepatocytes. Gastroenterology (1992) 1.43

Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer (1995) 1.43

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone. Gastroenterol Clin Biol (2010) 1.42

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol (2005) 1.39

Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum Mutat (1999) 1.34

Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol (2001) 1.33

Renal cell carcinoma containing fat: demonstration with CT. Radiology (1993) 1.29

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol (2009) 1.26

Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases. Cancer Chemother Pharmacol (2007) 1.22

Repeat liver resection for recurrent colorectal metastases. Br J Surg (1993) 1.20

Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br J Surg (1989) 1.16

Pharmacological effect of somatostatin on bile secretion in man. Digestion (1989) 1.11

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol (2011) 1.10

Operation and abdominal desmoid tumors in familial adenomatous polyposis. Surg Gynecol Obstet (1993) 1.09

Repeat hepatic resection for primary and metastatic carcinoma of the liver. Surg Gynecol Obstet (1990) 1.09

Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? J Urol (1996) 1.08

Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma. Br J Cancer (2006) 1.08

An experimental study of survival after two hours of normothermic hepatic ischemia. Surg Gynecol Obstet (1980) 1.07

Excision of the rectum with colonic J pouch-anal anastomosis for adenocarcinoma of the low and mid rectum. World J Surg (1992) 1.06

Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev (2012) 1.04

Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. Ann Surg (2000) 1.02

The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol (2008) 1.01

Liver resection with normothermic ischaemia exceeding 1 h. Br J Surg (1993) 1.01

Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut (1995) 1.00

Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study. Ann Surg (1998) 0.99

A report of forty-four instances of pancreaticoduodenal resection in patients more than seventy years of age. Surg Gynecol Obstet (1993) 0.99

High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer. Ann Oncol (1991) 0.98

Use of poly(DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton's jelly of the umbilical cord for promoting nerve regeneration in axonotmesis: in vitro and in vivo analysis. Differentiation (2012) 0.97

Quantifying recreational shore angling catch and harvest in southern Portugal (north-east Atlantic Ocean): implications for conservation and integrated fisheries management. J Fish Biol (2010) 0.97

Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience. Surgery (1996) 0.97

Rectopexy to the promontory for the treatment of rectal prolapse. Report of 257 cases. Dis Colon Rectum (1984) 0.96

Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy. Hepatology (1993) 0.96

No evidence of somatic FGFR3 mutation in various types of carcinoma. Oncogene (2001) 0.96

[Hepatectomy for tumor under vascular exclusion. Development of the ideas in the last decade. Apropos of experience with 41 cases]. Chirurgie (1983) 0.94

Interleukin-6 and TNF alpha production in human renal cell carcinoma. Kidney Int (1993) 0.94

Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Clin Cancer Res (1998) 0.93

HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation (2000) 0.93

Color Doppler US of renovascular disease in native kidneys. Radiographics (1995) 0.93

The healing of colonic anastomoses after early intraperitoneal chemotherapy: an experimental study in rats. J Surg Res (1988) 0.93

Where does pelvic nerve injury occur during rectal surgery for cancer? Colorectal Dis (2011) 0.93

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009. Ann Oncol (2010) 0.92

Renal lesions in von Hippel-Lindau disease: immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins. Histopathology (2000) 0.91

Growth and body proportions in congenital adrenal hyperplasia. Arch Dis Child (1989) 0.90

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis. Hepatology (1993) 0.88

[Place of nephrectomy in patients with autosomal dominant polycystic kidney disease waiting for renal transplantation]. Prog Urol (2008) 0.88

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology (1997) 0.88

Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. Arch Intern Med (1981) 0.87

Development of ternary and quaternary catalysts for the electrooxidation of glycerol. ScientificWorldJournal (2012) 0.87

Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes Chromosomes Cancer (1996) 0.87

[Diverting loop ileostomy, effective prevention of colonic complications in necrotizing acute pancreatitis]. Ann Chir (1992) 0.87

[Surgical resection of hepatic metastases of cancers of the colon and rectum]. Gastroenterol Clin Biol (1983) 0.87

Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases. Br J Cancer (2004) 0.86

Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G. Oncol Rep (2011) 0.86

Permeability and biocompatibility of a new hydrogel used for encapsulation of hepatocytes. Biomaterials (1995) 0.86

Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg (1993) 0.86

A reversible model of acute hepatic failure by temporary hepatic ischemia in the pig. J Surg Res (2000) 0.85

Percutaneous incision of stenotic uroenteric anastomoses with a cutting balloon catheter: long-term results. Radiology (2000) 0.84

Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors. Lab Invest (1994) 0.84

Suppression of humoral immunization against encapsulated xenogeneic hepatocytes and prolongation of their function by 2-week cyclosporine treatment in the rat. Surgery (2000) 0.84

Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy. J Neurochem (1983) 0.84

Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer. Br J Surg (1997) 0.84

[Digestive oncology: surgical practices]. J Chir (Paris) (2009) 0.84

Renal involvement in von Hippel-Lindau disease. Kidney Int (1996) 0.84

Experimental colorectal liver metastases. Influence of sex, immunological status and liver regeneration. J Hepatol (1990) 0.84

Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology (1997) 0.84

Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum (1993) 0.83

Secondary proctectomy and ileal pouch-anal anastomosis after ileorectal anastomosis for familial adenomatous polyposis. Br J Surg (1993) 0.83

[Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer]. Cancer Radiother (2013) 0.83

Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney. Eur J Pharmacol (1991) 0.83

Expression of bcl-2 oncoprotein in renal cell tumours. J Pathol (1995) 0.83

Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU. Ann Oncol (1993) 0.83